Presentation TCT 2016 The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status Presenter: Freek W.A. Verheugt, Pascal Vranckx, C. Michael Gibson November 01, 2016
Presentation TCT 2016 Controversy 5. Adjunctive Pharmacotherapy for TAVR: Real World Usage Patterns of Antiplatelet and Antithrombotic Agents Presenter: Raj Makkar, Lars Sondergaard, Luis Nombela-Franco October 31, 2016
Presentation TCT 2016 TCT 56: Validation of PARIS Risk Scores in a Large Multi-Ethnic PCI Cohort: Results From a Large Single-Center Registry Presenter: Neal S. Kleiman, David F. Kong, Usman Baber October 31, 2016
Presentation TCT 2016 TCT 55: RiskBenefit Analysis of Upstream Antithrombotic Therapy in Patients With NonST-Segment Elevation Acute Coronary Syndromes Prior to Coronary Angiography Presenter: Neal S. Kleiman, David F. Kong, Bjorn Redfors October 31, 2016
Presentation TCT 2016 TCT 54: LEADERS FREE OAC: Biolimus A9 Coated vs Bare Metal Stents in Patients Requiring Oral Anticoagulation. A Prespecified Subgroup Analysis of the LEADERS FREE Trial Presenter: Neal S. Kleiman, David F. Kong, Didier Carrié October 31, 2016
Presentation TCT 2016 TCT 53: Thromboembolic Event Rate Is Elevated With Lower Adherence to Warfarin and NOACs Presenter: Neal S. Kleiman, David F. Kong, Jeffrey R Winterfield October 31, 2016
Presentation TCT 2016 TCT 27: Transcatheter Left Atrial Appendage Occlusion Using Aspirin Alone for Post-Implant Antithrombotic Therapy Presenter: Zahid Amin, Jacqueline Saw, Jens Erik Nielsen-Kudsk October 31, 2016
News Conference News TCT 2016 Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions Michael O'Riordan October 31, 2016
Presentation TCT 2016 New Techniques, New Antithrombotic Therapies Presenter: Guy J. Friedrich, Kurt Huber, Matej Samos October 31, 2016
Presentation TCT 2015 TCT 103: National Variation in Post-TAVR Antithrombotic Therapy Utilization and Associated Outcomes Insights From the STS/ACC TVT Registry Presenter: Michael J. Reardon, Torsten P. Vahl, Matthew Sherwood October 13, 2015
News Conference News TCT 2015 Discussion Highlights Merits, Limitations of Small Trials Yael L. Maxwell October 13, 2015
News Conference News TCT 2014 Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation Todd Neale October 10, 2014
Presentation TCT 2014 TCT 475: Triple Antithrombotic Therapy Versus Dual Antiplatelet Therapy in Patients with Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Dong Oh Kang September 15, 2014
Presentation TCT 2014 TCT 474: Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndromes: The AVIATOR Registry Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Georgios Christodoulidis September 15, 2014
News Conference News TCT 2014 PLATO Subanalysis: Ticagrelor Safe, Effective in Primary PCI September 15, 2014
News Conference News TCT 2014 Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES Todd Neale September 13, 2014
News Conference News TCT 2014 Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI September 13, 2014
News Conference News TCT 2014 ISAR-CLOSURE: Vascular Closure Devices Noninferior to Manual Compression in Transfemoral Angiography September 13, 2014
Presentation TCT 2013 Outcomes of Patients Treated with Triple Antithrombotic Therapy After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (From the Harmonizing... Presenter: Eugenia Nikolsky October 31, 2013